Ladenburg Thalmann Downgrades Allarity Therapeutics to Neutral
Ladenburg Thalmann analyst Aydin Huseynov downgrades Allarity Therapeutics (NASDAQ:ALLR) from Buy to Neutral.
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Allarity Therapeutics Granted Granted European Patent Titled ‘METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS’
https://data.epo.org/publication-server/pdf-document?pn=3404118&ki=B1&cc=EP
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 50 companies set new 52-week lows.